Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05988385 · ClinicalTrials.gov registry record · NA
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
A NA study of Obstructive Sleep Apnea and Cognitive Decline, sponsored by California Pacific Medical Center Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 4
- Study locations
NCT05988385: Recruiting NA study of Obstructive Sleep Apnea and Cognitive Decline, sponsored by California Pacific Medical Center Research Institute.
NCT05988385 is a NA study of Obstructive Sleep Apnea and Cognitive Decline that is actively recruiting participants, run by California Pacific Medical Center Research Institute. The registered enrollment target is 200 participants, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05988385, a NA study of Obstructive Sleep Apnea and Cognitive Decline, is actively recruiting participants, sponsored by California Pacific Medical Center Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 4
- Study locations
Study Summary
The Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) study is a 5-year, multicenter randomized open-label trial that will screen 400 cognitively normal older adults recruited from well-established sleep clinics at 4 academic medical centers, with newly diagnosed moderate-severe OSA. An expected 200 OSA patients will be then randomized to one of two groups: i) a 3-month OSA treatment by any combination of PAP, OAT, and positional therapy that results in an "effective" AHI4%\< 10/hour and AHI3A\<20/hour (see below); ii) a waitlist control group to receive treatment at the conclusion of the 3-month intervention period. Both groups will continue follow-up for 24 months on stable therapy to determine if sustained improvements in sleep are associated with improvement in cognitive function and AD biomarkers.
Primary Outcome
Mean change in percent correct memory
Conditions Studied
Interventions
- DEVICE Positive airway pressure
- DEVICE Oral appliance therapy
- DEVICE Positional therapy
Study Locations (4)
New York
- New York University - New York
- Mount Sinai - New York
Arizona
- University of Arizona - Tucson
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-04-22 |
| Est. Completion | 2028-05-31 |
| Phase | NA |
What NCT05988385 shows while recruiting
NCT05988385 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target.
The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 3 interventions - of which Positive airway pressure is the first listed.
NCT05988385 reports a single indexed study location in New York, Arizona, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05988385 about?
NCT05988385 is a clinical study titled "The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study". The Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) study is a 5-year, multicenter randomized open-label trial that will screen 400 cognitively normal older adults recruited from well-established sleep clinics at 4 academic medical centers, with newly diag...
What is the current status of trial NCT05988385?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-04-22. Estimated completion is 2028-05-31.
What conditions does trial NCT05988385 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Cognitive Decline.
What interventions are being tested in trial NCT05988385?
The interventions under investigation include: Positive airway pressure (DEVICE), Oral appliance therapy (DEVICE), Positional therapy (DEVICE).
Who is sponsoring clinical trial NCT05988385?
This trial is sponsored by California Pacific Medical Center Research Institute, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05988385 being conducted?
This trial has 4 study locations across Arizona, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05988385's enrollment target sits among peer trials
200 39th of 155 higher than 113 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI